These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10414837)

  • 21. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.
    Postma MJ; Jansema P; van Genugten ML; Heijnen ML; Jager JC; de Jong-van den Berg LT
    Drugs; 2002; 62(7):1013-24. PubMed ID: 11985488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct, indirect and intangible costs of acute hand and wrist injuries: A systematic review.
    Robinson LS; Sarkies M; Brown T; O'Brien L
    Injury; 2016 Dec; 47(12):2614-2626. PubMed ID: 27751502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value for money in the health sector: the contribution of primary health care.
    Mills A; Drummond M
    Health Policy Plan; 1987 Jun; 2(2):107-28. PubMed ID: 10312103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic evaluations and diabetes.
    Pathak DS; Burke TA
    Pharm Pract Manag Q; 1998 Jan; 17(4):17-24. PubMed ID: 10174745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost measurement of mental disorders in Germany.
    Grupp H; Köenig HH; Konnopka A
    J Ment Health Policy Econ; 2014 Mar; 17(1):3-8. PubMed ID: 24864116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in economic outcomes research.
    Cook JR
    Hepatology; 1999 Jun; 29(6 Suppl):23S-25S. PubMed ID: 10386079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preference-based measures in economic evaluation in health care.
    Neumann PJ; Goldie SJ; Weinstein MC
    Annu Rev Public Health; 2000; 21():587-611. PubMed ID: 10884966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biases in cost measurement for economic evaluation studies in health care.
    Jacobs P; Baladi JF
    Health Econ; 1996; 5(6):525-9. PubMed ID: 9003939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inconsistencies in the "societal perspective" on costs of the Panel on Cost-Effectiveness in Health and Medicine.
    Meltzer D; Johannesson M
    Med Decis Making; 1999; 19(4):371-7. PubMed ID: 10520672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation of alcoholism treatment.
    Bray JW; Zarkin GA
    Alcohol Res Health; 2006; 29(1):27-33. PubMed ID: 16767850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discounting in cost-utility analysis of healthcare interventions: reassessing current practice.
    Cohen BJ
    Pharmacoeconomics; 2003; 21(2):75-87. PubMed ID: 12515570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. REFLECTIONS ON THE NICE DECISION TO REJECT PATIENT PRODUCTION LOSSES.
    Shearer J; Byford S; Birch S
    Int J Technol Assess Health Care; 2017 Jan; 33(6):638-643. PubMed ID: 29151390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social costs of expanding access to evidence-based supported employment: concepts and interpretive review of evidence.
    Salkever D
    Psychiatr Serv; 2013 Feb; 64(2):111-9. PubMed ID: 23117344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stakeholder perspectives on costs and resource expenditures: tools for addressing economic issues most relevant to patients, providers, and clinics.
    Jones Rhodes WC; Ritzwoller DP; Glasgow RE
    Transl Behav Med; 2018 Sep; 8(5):675-682. PubMed ID: 29590479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using economic evaluations to reduce the burden of asthma and chronic obstructive pulmonary disease.
    Sculpher M
    Pharmacoeconomics; 2001; 19 Suppl 2():21-5. PubMed ID: 11700785
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.